Muutke küpsiste eelistusi

Medical and Health Genomics [Kõva köide]

Edited by (University of Geneva Medical School, Geneva, Switzerland), Edited by (Honorary Clinical Professor, William Harvey Research Institute, Queen Mary University of London, UK)
  • Formaat: Hardback, 358 pages, kõrgus x laius: 276x216 mm, kaal: 1250 g, 50; Illustrations, unspecified
  • Ilmumisaeg: 24-Jun-2016
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0124201962
  • ISBN-13: 9780124201965
Teised raamatud teemal:
  • Formaat: Hardback, 358 pages, kõrgus x laius: 276x216 mm, kaal: 1250 g, 50; Illustrations, unspecified
  • Ilmumisaeg: 24-Jun-2016
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0124201962
  • ISBN-13: 9780124201965
Teised raamatud teemal:
Medical and Health Genomics provides concise and evidence-based technical and practical information on the applied and translational aspects of genome sciences and the technologies related to non-clinical medicine and public health.Coverage is based on evolving paradigms of genomic medicine, in particular, the relation to public and population health genomics now being rapidly incorporated in health management and administration, with further implications for clinical population and disease management.Provides extensive coverage of the emergent field of health genomics and its huge relevance to healthcare managementPresents user-friendly language accompanied by explanatory diagrams, figures, and many references for further studyCovers the applied, but non-clinical, sciences across disease discovery, genetic analysis, genetic screening, and prevention and managementDetails the impact of clinical genomics across a diverse array of public and community health issues, and within a variety of global healthcare systems

Muu info

This timely book examines the impact of clinical genomics across an array of public and community health issues, and within a variety of global healthcare systems offering concise, evidence-based technical and practical information on applied and translational aspects of genome sciences and technologies related to clinical medicine and public health
List of Contributors xi
Foreword xiii
Preface xv
1 The Human Genome
D. Kumar
Introduction
1(1)
Hereditary Factors, Genes, Genetics, and Genomics
1(1)
Structure and Organization of Nucleic Acids
2(3)
Human Genome Variation and Human Disease
5(3)
Measuring Genetic and Genomic Variation
6(1)
Genome Variation and Human Disease
7(1)
The Mitochondria! Genome
8(1)
Functional Genomics, Transcriptomics, and Proteomics
9(1)
Translational Human Genomics
10(1)
Human Genomics for Socioeconomic Development
11(1)
Conclusions
12(1)
References
12(3)
2 Genomic Technologies in Medicine and Health: Past, Present, and Future
Y.H. Rogers
C. Zhang
Introduction
15(1)
Sequencing Technologies
16(1)
Computational and Information Technologies
16(1)
Applications of Genomic Technologies
17(1)
The Microbiome and Human Health
18(1)
The Pediatric Microbiome
18(1)
The Microbiome and Oral Health
18(1)
The Microbiome and Gastrointestinal Health
18(1)
The 1000 Genomes Project and Structural Variations in the Human Genomes
18(1)
Noninvasive Prenatal Testing by Sequencing of Cell-Free Fetal DNA in the Maternal Blood
19(1)
Prenatal Diagnosis by Whole Genome Sequencing of "Jumping Libraries"
19(1)
Postnatal Diagnosis
20(1)
Genome Sequencing in Newborn Healthcare
21(1)
Genome Sequencing in Other Research Areas
22(1)
The Cancer Genome Atlas and Cancer Genomics
22(1)
Cancer Diagnosis
22(1)
Precision Medicine
23(2)
Development of Targeted Therapeutics for Genetic Disorders
23(1)
Development of Targeted Therapeutics for Cancers
24(1)
Genomic Profiling and Counseling
24(1)
The Precision Medicine Initiative
24(1)
Policy and Regulatory Issues
25(1)
Genomic Education
25(1)
References
25(4)
3 Genomic Databases, Access Review, and Data Access Committees
M. Shabani
B.M. Knoppers
P. Bony
Introduction
29(1)
Underlying Principles, Policies, and Guidelines
30(1)
Examples of Controlled-Access Databases and Pertinent Data Access Committees
30(2)
European Genome-phenome Archive
30(1)
Database of Genotypes and Phenotypes
31(1)
Ethical and Legal Challenges
32(2)
Consent
32(1)
Oversight Mechanisms on Downstream Uses and Enforceability
33(1)
Data Producers and Data Users' Interests and Benefits
33(1)
Conclusion
34(1)
Acknowledgments
34(1)
References
34(3)
4 Diagnostic Genomics and Clinical Bioinformatics
A. Haworth
H. Savage
N. Lench
Introduction
37(5)
Current Clinical Practice: Diagnosis
37(1)
Chromosomal Microarrays
37(1)
Single Gene Testing
38(1)
Gene Panel Testing
38(1)
Exome Sequencing
39(1)
Whole Genome Sequencing
39(1)
Diagnostic Testing Strategy
39(1)
Inherited Cardiac Conditions
40(1)
Hypertrophic Cardiomyopathy
40(1)
Aortopathies
40(1)
Intellectual Disability
41(1)
Deciphering Developmental Disorders
41(1)
The UK100K Genomes Project: Large-Scale Implementation of Whole Genome Sequencing
42(6)
Clinical Bioinformatics
42(1)
Clinical Phenotyping
42(1)
Bioinformatics Pipelines
43(1)
Reference Genome
43(1)
Interpretation of DNA Sequence Variants
44(1)
Protein-Altering Variants
45(1)
Variants Causing Aberrant Messenger RNA Splicing
45(1)
Nucleotide Conservation
45(1)
Inheritance and Mutation Type
45(1)
Segregation Analysis
45(1)
Mutational Mechanism and Variant Spectrum
46(1)
De Novo Mutations
46(1)
Functional Evidence
46(1)
Databases and Literature
46(1)
Literature Databases
47(1)
Online Mendelian Inheritance in Man
47(1)
Incidental Findings
47(1)
Data Sharing
48(1)
Conclusion
48(1)
References
48(3)
5 Epigenetics and Epigenomics in Human Health and Disease
R. Festenstein
Introduction
51(1)
Epigenotype and Regulation of Gene Expression
51(2)
Epigenotypes and Human Disease
53(9)
Trinucleotide Repeats and Human Disease
54(1)
Friedreich Ataxia
54(1)
Myotonic Dystrophy
55(1)
Fragile X Syndrome
56(1)
Facioscapulohumeral Dystrophy
57(2)
Immunodeficiency, Centromeric Region Instability, and Facial Anomalies Syndrome: Genetic Mutations Causing Methylation
59(1)
Rett Syndrome
60(1)
alpha-Thalassemia X-Linked Mental Retardation Syndrome
61(1)
Epigenetic Mechanisms in Cancer
62(1)
Conclusion
63(1)
Acknowledgment
63(1)
References
63(12)
6 Mitochondrial Genomics: Emerging Paradigms and Challenges
V. Singh
P. Gupta
N.K. Rajput
A. Bhardwaj
Introduction
75(1)
Nongenetic Diagnostics for Mitochondrial Dysfunction
75(3)
Genome Data Deluge
78(1)
DNA Testing, Next Generation Sequencing, and Mitochondrial Disease Diagnosis
79(1)
Next Generation Sequencing
80(1)
Next Generation Sequencing-Based Diagnostic Assay Design for Mitochondrial Disorders
80(1)
Translational Advancements
81(3)
Semantic Data Standards for Community Collaboration
84(1)
The Road Ahead
85(1)
Conclusions
85(1)
References
86(3)
7 The Significance of Metabolomics in Human Health
D.F. Gomez-Casati
M. Grisolia
M.V. Busi
Introduction
89(1)
Metabolomics in Human Diseases
90(3)
Biomarker Detection
93(1)
Group Discrimination (Diagnosis)
93(1)
Inborn Metabolic Disorders
93(1)
Cancer Metabolomics
94(1)
Biomarkers for Psychiatric Diseases
94(1)
Metabolomics in Environmental and Public Health
95(1)
Human Nutrition
96(1)
Intestinal Metabolome
96(1)
Conclusions
97(1)
Acknowledgment
98(1)
References
98(3)
8 Microbial Genomics: Diagnosis, Prevention, and Treatment
A. Mutreja
Background
101(1)
Control and Prevention
101(2)
Treatment and Diagnostics
103(2)
References
105(2)
9 A Metagenomic Insight Into the Human Microbiome: Its Implications in Health and Disease
R. Saxena
V.K. Sharma
Outline of the
Chapter
107(1)
Introduction
107(2)
Human-Associated Microflora
109(1)
Alterations in the Healthy Human Microbiome: Association With Diseases
110(1)
The Oral Microbiome
110(1)
The Skin Microbiome
111(1)
The Gut Microbiome
111(4)
Diseases Associated With Variation in the Gut Microbial Community
112(3)
Novel Therapeutic Strategies Based on the Human-Associated Microbiome
115(1)
Conclusion
116(1)
Glossary
117(1)
List of Acronyms and Abbreviations
117(1)
References
117(4)
10 Pharmacogenetics and Pharmacogenomics
A. Alfirevic
M. Pirmohamed
Introduction
121(1)
Pharmacogenomic Information in Drug Labeling
122(2)
Pharmacogenetic Guidelines
124(1)
Pharmacogenetic Study Design
124(2)
Clinical Areas
126(7)
Conclusions
133(1)
References
134(5)
11 Medical and Health Aspects of Genetics and Genomics
D. Kumar
Introduction
139(2)
Chromosomal Disorders
141(1)
Mendelian (Single-Gene) Disorders
142(1)
Polygenic or Multifactorial Disorders
142(2)
Mitochondria! Genetic Disorders
144(1)
Genomic Disorders
145(12)
Disorders of Genomic Imprinting: Epigenetic Diseases
145(5)
Disorders of the Genome Architecture
150(5)
Disorders With Trinucleotide (Triplet) Repeats
155(1)
Complex Genomic Diseases
156(1)
Disease Spectrum, Biological Pathways, and Genotypes
157(2)
Summary
159(1)
References
159(2)
12 Content and Variation of the Human Genome
S.E. Antonarakis
Introduction: "The Genome Anatomy"
161(9)
Protein-Coding Genes
165(1)
Noncoding, RNA-Only Genes
166(2)
Regions of Transcription Regulation
168(1)
Conserved Elements Not Included in the Previous Categories
168(1)
Repetitive Elements
168(1)
Segmental Duplications
169(1)
Special Genomic Structures Containing Selected Repeats
170(6)
Human Centromeres
170(1)
Human Telomeres
171(1)
Short Arms of Human Acrocentric Chromosomes
171(1)
Mitochondrial Genome
172(1)
Genomic Variability
172(4)
Genome Variation as a Laboratory Tool to Understand the Genome
176(1)
References
176(3)
13 Spectrum of Genetic Diseases and Management
B. Kerr
Introduction
179(1)
Molecular Approach to Genetic Disease Nosology
179(1)
From Marfan Syndrome to Fibrillinopathies
180(4)
Diagnosis of Marfan Syndrome
182(1)
Differential Diagnosis
182(1)
Management of Marfan Syndrome
183(1)
Treatment
183(1)
The Emergence of RASopathies
184(2)
Malignancy Risk in RASopathies
185(1)
Making a Diagnosis of a Genetic Disorder in the Era of Molecular Pathways
186(1)
Conclusion
187(1)
References
187(4)
14 Genomic Analysis in Clinical Practice: What Are the Challenges?
A. Lucassen
I. van Langen
Introduction
191(1)
Consent for Genome Testing in Clinical Practice
191(4)
Incidental Findings
195(2)
Management of Incidental Findings
195(2)
The Data Interpretation Problem
197(1)
What Constitutes a Result in Genomic Medicine?
197(1)
Diagnostic Versus Population Screening
198(1)
Conclusions
198(1)
References
198(3)
15 Genomic Perspective of Genetic Counseling
C.L. Gaff
I. Macciocca
Introduction
201(1)
Ethos and Principles of Genetic Counseling
201(1)
Elements of Genetic Counseling
202(1)
Counseling Issues
203(2)
Uncertainty
203(1)
Confidentiality and Privacy of Genomic Data
203(1)
Secondary Findings
204(1)
Family Communication
205(1)
The "Healthy Genome"
205(1)
Case Study
205(1)
Practicalities of Counseling for Genomic Tests
206(4)
Genetic Information Is Key
209(1)
Patient Autonomy Must Be Supported
210(1)
Patient Emotions Make a Difference
210(1)
Relationship Is Integral to Genetic Counseling
210(1)
Conclusion
210(1)
Acknowledgment
210(1)
References
210(3)
16 Genetics and Genomics of Reproductive Medicine and Health
D. Kumar
Introduction
213(1)
Female Infertility
213(5)
Congenital Anomalies of the Reproductive Tract
213(1)
Disorders of Abnormal Ovulation
214(3)
Disorders of the Endometrium
217(1)
Male Factor Infertility
218(3)
Congenital Anomalies of the Male Reproductive Tract
218(1)
Molecular Genetics of Male Factor Infertility
219(2)
Mitochondrial Genes in Male Factor Infertility
221(1)
New Genomic Applications in Male Factor Infertility
221(1)
Genetic Factors in In Vitro Fertilization
221(2)
Preimplantation Genetic Testing and Screening
222(1)
Recent Advances in Prenatal Diagnosis
223(1)
Aneuploidy (Trisomy 21) Pregnancy
223(1)
Cell-Free Fetal DNA
223(1)
Summary
224(1)
References
224(3)
17 Stratified and Precision Medicine
D. Kumar
Introduction
227(1)
Molecular, Genetic, and Genomic Revolutions in Medicine
227(1)
Personalized Medicine
228(2)
Stratified Medicine
230(4)
Challenges for Stratified Medicine
232(1)
The Future of Stratified Medicine
233(1)
Summary
234(1)
References
234(3)
18 Teaching and Training Medicine in Genomic Era
B. Korf
Introduction
237(1)
Integration of Genomics into Medical Practice
237(5)
The Practice of Genomic Medicine
238(2)
The Roles of the Geneticist and Nongeneticist Health Providers
240(1)
Competencies Required in Genomic Medicine
241(1)
Genomics and the Medical Education Landscape
242(1)
Premedical Education
242(1)
Medical School
242(1)
Residency Education
242(1)
Postgraduate Education
243(1)
Approaches to Medical Genomics Education
243(1)
Medical School
243(1)
Residency Education
244(1)
Continuing Medical Education
244(1)
Conclusions and Final Comments
244(1)
References
244(3)
19 Genomics, New Drug Development, and Precision Medicines
D. McHale
M. Penny
Introduction
247(3)
The Drug Discovery and Development Process
248(1)
Preclinical Testing
248(1)
Clinical Development
249(1)
Applying Genomics to Drug Discovery
250(3)
Choosing the Best Drug Targets
250(1)
Complex Trait Genetics
251(1)
Single Gene Disorders/Traits
251(1)
Drug-Specific Targets Approach
252(1)
Applying Pharmacogenetics to Drug Development
253(2)
Pharmacodynamic Variability
253(1)
Pharmacokinetic Variability
254(1)
Predicting Safety
255(2)
Predicting Type B Adverse Events
255(1)
Predicting Type A Adverse Events
255(1)
Individualized Therapy: An Integrated Response
256(1)
Improving Disease Classification: Stratified Medicines
256(1)
Adverse Drug Reactions
257(1)
Summary
257(1)
References
258(3)
20 Cancer Genetics and Genomics
J. Whitworth
E. Maher
Introduction
261(1)
Inherited Cancers: Germ Line and Somatic
261(3)
Oncogenes, Tumor Suppressor Genes, and the Identification of Cancer Predisposition Genes
261(1)
Identifying Cancer Predisposition Genes
262(1)
High, Medium, and Smaller Risks
263(1)
Genetic Testing in Cancer Predisposition Syndromes
264(2)
Risk Information as Therapy
264(1)
Cancer Surveillance
265(1)
Prophylactic Surgery
265(1)
Pharmacological Management
266(1)
Inherited Cancer Genes
266(15)
Phenotypic Effects of Mutations in Cancer Predisposition Genes
266(14)
Genotype-Phenotype Correlation
280(1)
Genetic Testing and Mainstreaming
281(2)
Genetic Testing and Next Generation Sequencing
281(1)
Reasons for Nondetection of Causative Genetic Changes Through Clinical Testing
282(1)
Conclusion
283(1)
References
283(2)
21 The Provision of Medical and Health Genetics and Genomics in the Developing World
N. Sirisena
D. Sumathipala
K. Wettasinghe
V.H.W. Dissanayake
Introduction
285(2)
Public Health Programs in Genetics and Genomics
287(3)
Medical Services Incorporating Genetics and Genomics
290(3)
Summary
293(1)
References
293(2)
22 Genomic Applications in Forensic Medicine
C. Bursting
N. Morling
Introduction
295(2)
The Basics of Next Generation Sequencing
297(2)
Single Molecule Sequencing
299(1)
Next Generation Sequencing Solutions in Forensic Genetics
300(6)
Short Tandem Repeat Sequencing
302(1)
The First Commercial Next Generation Sequencing Kits for Forensic Genetics
303(2)
New Frontiers in Forensic Genetics
305(1)
Concluding Remarks
306(1)
Acknowledgment
307(1)
References
307(4)
23 Public and Population Health Genomics
A.L. Wise
T.A. Manolio
Introduction
311(1)
Breast Cancer
311(1)
Colorectal Cancer
312(1)
Bronchial Asthma
313(1)
Crohn Disease
313(1)
Alzheimer Dementia
313(2)
Cystic Fibrosis
315(1)
Cross-Cutting Issues of Population Genomics
315(1)
Summary
316(1)
References
316(3)
Glossary 319(8)
Index 327
Professor Kumar has considerable previous experience in writing and editing books and journals related to genetics and genomics. His books include Genomics and Clinical Medicine and Genomics and Health in the Developing World. He founded and leads the new open access journal Applied and Translational Genomics, published by Elsevier. He has published 40 articles in the journals literature. Professor Dhavendra Kumar is a Visiting Professor, Genomic Policy Unit, Faculty of Life Sciences and Education, The University of South Wales and Consultant in Clinical Genetics at the University Hospital of Wales, Institute of Medical Genetics, Cardiff University, Cardiff, United Kingdom. He is one of the Consultants for the All Wales Medical Genetics Service and the lead Clinician for Clinical Cardiovascular Genetics. After qualifying in Medicine from the King Georges Medical College, University of Lucknow, India, he completed postgraduate training in Pediatrics with an MD. Since 1980 he has pursued a career in Medical Genetics in the UK. In 1990 he became a Diplomate of the American Board of Medical Genetics. He is a Fellow of the American College of Medical Genetics (FACMG) and as well as Royal Colleges of Physicians (FRCP-London and FRCP-Ireland) and Pediatrics and Child Health (FRCPCH-UK).

In 2015, he was conferred with the higher degree of DSc by his Alma Mater, King Georges Medical University, Lucknow (UP, India) based on his life-time contributions and achievements to genetic and genomic applications in medicine and health.